Key Points:
Browsing: Healthcare Industry
Key Points: This adoption of EvoEndo at Orlando Health Arnold Palmer Hospital signifies a significant advancement in pediatric gastrointestinal care,…
Two retrospective analyses have revealed that the introduction of biosimilars has reduced the costs of the originator biologic, infliximab, but…
As artificial intelligence (AI) becomes increasingly integrated into healthcare, U.S. federal lawmakers are considering how to regulate its use to…
Healthcare leaders are turning to gastroenterology to unlock growth opportunities. Here are how three leaders are using gastroenterology to grow…
Physician groups have welcomed a new federal rule announced on January 17, which requires health insurers to streamline and disclose…
The US National Comprehensive Cancer Network (NCCN) has issued guidelines stating that post-surgical circulating tumor DNA (ctDNA) is an emerging…
An initiative at the University of North Carolina health system successfully increased the use of biosimilars in rheumatology and gastroenterology…
The new final rule, set to be enforced from January 1, 2026, aims to streamline and digitize the prior authorization…
In November, Blue Cross Blue Shield Massachusetts announced that beginning Jan. 1, it would no longer cover the use of…